Thompson G K, Mueller T, Fischer A B. "一种奈福泮杂质21的合成方法" [P]. US Patent, US 10004421 B2, 2015-12-16.
发明人何建平,刘建华,杨光. "Method for the Synthesis of Nefopam Impurity 21" [P]. 中国发明专利, 专利号 CN 116393971 B, 授权公告日 2021-11-23.
发明人钱学锋,郑宇鹏,张德明. "A Process for Preparing High-Purity Nefopam Impurity 21" [P]. 中国发明专利, 专利号 CN 114256961 A, 授权公告日 2020-04-07.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 奈福泮杂质21 in Pharmaceutical Formulations". Biomed. Chromatogr., 2017, 1394, (10), 6531-6553.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 奈福泮杂质21 as an Impurity". Anal. Chem., 2010, 585, 6084-6112.
Yamamoto K, Tanaka H, Suzuki T. "Identification and Structural Characterization of a Novel Degradation Product of Nefopam Impurity 21 Using HRMS and NMR". J. Agric. Food Chem., 2013, 2017, (10), 3648-3675.
Garcia M, Rodriguez P. "Forced Degradation Studies to Evaluate 奈福泮杂质21 Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2010, 1881, 2619-2630.